Correcting -- Hyloris reports results for the full year

Added 4 additional innovative product candidates Strong growth in H2 leading to total revenues of €3.1 million (€0.2 million in 2020) Significant...

Related Keywords

Canada ,Norway ,Malaysia ,Australia ,United Kingdom ,Luxembourg ,Austria ,Woman ,Bahrain ,Pakistan ,Germany ,Mexico ,Iceland ,Thailand ,New Zealand ,Denmark ,Netherlands ,Israel ,Belgium ,Albania ,Italy ,Ireland ,South Korea ,Panama ,France ,Spain ,Cyprus ,Greece ,Belgian ,Abid Irshad ,Thomas Jacobsen ,Vaneltix Pharma ,Vulvovaginal Candidiasis ,Stijn Van Rompay ,Jean Luc Vandebroek ,Chris Buyse ,Academic Pharmaceuticals ,Delveinsight Market Research ,Hyloris Pharmaceuticals Sa Euronext Brussels ,Department Of Radiology ,University Of South Carolina College Medicine ,Leukemia Lymphoma Society ,Business Development ,Euronext Brussels ,Chief Executive Officer ,Delveinsight Market ,Domiphen Bromide ,Purna Female Healthcare ,Recurrent Vulvovaginal Candidiasis ,Pleco Therapeutics ,Healthcare April ,Lymphoma Society ,Associate Professor ,Medical University ,South Carolina College ,Fusidic Acid Cream ,Fusidic Acid ,Chief Business Development Officer ,Chief Financial Officer ,Managing Director ,Brussels Stock Exchange Hyl ,Hyloris Pharmaceuticals Sa ,